Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

From Verus to Meritage: A Biotech Prototype for Tough Economic Times

This article was originally published in Start Up

Executive Summary

Prolific entrepreneur Cam Garner has a new model for start-ups. Gone are the days of raising huge A rounds to build commercial infrastructure and license in families of products. His two new firms, Meritage and Evoke, are narrowly focused on single assets, in each case a reformulation of an approved drug repositioned in an underserved specialty indication.

You may also be interested in...



Meritage Weighs Its Options As It Looks Toward Phase III

Meritage Pharma announced Phase II results of its EoE drug, with hopes of being the first to market in the indication.

Meritage Weighs Its Options As It Looks Toward Phase III

Meritage Pharma announced Phase II results of its EoE drug, with hopes of being the first to market in the indication.

Safety Problems Help AstraZeneca Win Suit Brought By Former Partner Verus

AstraZeneca is in a strange position for a pharmaceutical company: It has benefited in court because of safety problems observed in one of its products

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC091756

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel